Assess Safety and Probable Benefit of the EXCOR® Pediatric Ventricular Assist Device Under a Continued Access Protocol

NCT01242891 · Status: APPROVED_FOR_MARKETING · Type: EXPANDED_ACCESS

Last updated 2012-03-06

No results posted yet for this study

Summary

The main purpose of this protocol is to provide a mechanism for continued access for patients that would have been enrolled into the primary cohorts of the IDE study.

Conditions

Interventions

DEVICE

EXCOR® Pediatric Ventricular Assist Device

Extracorporeal Ventricular Assist Device

Sponsors & Collaborators

  • Berlin Heart, Inc

    lead INDUSTRY

Principal Investigators

  • All Previous IDE Sites · See IDE Clinical Trials Listing for IDE Study

Eligibility

Min Age
1 Day
Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01242891 on ClinicalTrials.gov